MOTUS GI HOLDINGS, INC.

Analyst Reco. Motus GI Holdings, Inc.

Equities

MOTS

US62014P5044

Market Closed - OTC Markets Other stock markets 20:36:48 01/05/2024 BST			5-day change	1st Jan Change
0.072 ^USD	-5.25%		+2.86%	-94.35%

04-18	Motus GI Holdings, Inc.(OTCPK:MOTS) dropped from S&P TMI Index	CI
04-15	Motus GI Holdings, Inc.(OTCPK:MOTS) dropped from NASDAQ Composite Index	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Exchange-Traded Funds, US Equities Rise Pre-Bell Tuesday as Investors Continue to Hope for Federal Reserve Rate Cuts Soon	12-19	MT
HC Wainwright Adjusts Price Target on Motus GI to $2.50 From $10, Maintains Buy Rating	15/06/23	MT
Oppenheimer Adjusts Motus GI Holdings Price Target to $5 From $11, Maintains Outperform Rating	16/11/22	MT
HC Wainwright Adjusts Price Target on Motus GI Holdings to $10 From $11, Maintains Buy Rating	15/11/22	MT
Piper Sandler Adjusts Price Target on Motus GI Holdings to $6 From $10, Maintains Overweight Rating	15/11/22	MT
HC Wainwright Adjusts Price Target on Motus GI Holdings to $11 From $20, Reiterates Buy Rating	15/08/22	MT
Alliance Global Adjusts Price Target on Motus GI Holdings to $12 From $24, Reiterates Buy Rating	11/08/22	MT
HC Wainwright Trims Motus GI Holdings' Price Target to $1.50 From $2, Maintains Buy Rating	16/05/22	MT
Oppenheimer Adjusts Motus GI Holdings Price Target to $1.65 From $2, Maintains Outperform Rating	26/04/22	MT
MOTUS GI : HC Wainwright Adjusts Motus GI Holdings' Price Target to $2 From $3, Keeps at Buy	16/11/20	MT
MOTUS GI : Oppenheimer Adjusts Motus GI Holdings' Price Target to $2.25 From $2.50, Maintains Outperform Rating	13/11/20	MT
Motus GI Holdings, Inc. Announces EXPEDITE Study Initiated by Boston Medical Center to Evaluate Clinical Effectiveness of Pure-Vu® System for Improving Bowel Preparation Rates	11/11/19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer